-
Synthetic Protein Maker Raises $91.3M in Venture Funds
A company creating animal-free designer proteins for skin care products is raising more than $91 million in its second venture funding round.
-
Covid-19 Vaccines, Therapies – 27 July 2020
This week’s chart shows since last Monday more new activity for therapies than vaccines, with 15 new Covid-19 therapies joining the array of treatments in development.
-
Infographic – Social Media Seen Having Too Much Power
Majorities of Americans say social media companies have too much power and influence in politics, a view that cuts across ideologies and parties.
-
Venture Funding Down in 2020, Life Sciences Stay Hot
For the first half of 2020, venture investing declined compared to 2019, but life science and biotechnology investments continued growing for the year.
-
Synthetic Protein Designed to Boost Covid-19 Vaccines
Researchers in Texas designed a synthetic version of a protein found on Covid-19 viruses that can make it easier to produce more vaccines.
-
Advanced Solid Tumor Precision Meds. Trial Begins
A clinical trial is underway testing a treatment for advanced-stage cancers that blocks amino acids allowing nutrients to feed the growth of solid tumors.
-
Trial Testing Point-of-Care Covid-19 Diagnostic
A clinical trial in the U.K. is assessing a testing device to detect Covid-19 viruses in nasal swab samples that returns results in an hour.
-
NIH Expands Covid-19 Test Technology Challenge
National Institutes of Health is expanding its challenge competition to make tests for Covid-19 viruses more widely available and return results faster.
-
Start-Up Developing Inside-Cell Delivery, Gains $28.5M
A new company spun-off from Harvard University is developing techniques for delivering advanced genetic and protein therapies directly inside cells.
-
Tough Surgical Adhesive Commercially Licensed
A bio-materials company is acquiring the rights to develop dental sutures and membranes from an adhesive gel developed in a university lab.